| Literature DB >> 32101747 |
Kaustav Das Gupta1, Melanie R Shakespear1, James E B Curson1, Ambika M V Murthy1, Abishek Iyer2, Mark P Hodson3, Divya Ramnath1, Vikas A Tillu4, Jessica B von Pein1, Robert C Reid2, Kathryn Tunny4, Daniel M Hohenhaus4, Shayli Varasteh Moradi5, Gregory M Kelly4, Takumi Kobayashi6, Jennifer H Gunter7, Alexander J Stevenson4, Weijun Xu2, Lin Luo1, Alun Jones4, Wayne A Johnston5, Antje Blumenthal6, Kirill Alexandrov5, Brett M Collins4, Jennifer L Stow1, David P Fairlie2, Matthew J Sweet8.
Abstract
Histone deacetylases (HDACs) drive innate immune cell-mediated inflammation. Here we identify class IIa HDACs as key molecular links between Toll-like receptor (TLR)-inducible aerobic glycolysis and macrophage inflammatory responses. A proteomic screen identified the glycolytic enzyme pyruvate kinase M isoform 2 (Pkm2) as a partner of proinflammatory Hdac7 in murine macrophages. Myeloid-specific Hdac7 overexpression in transgenic mice amplifies lipopolysaccharide (LPS)-inducible lactate and promotes a glycolysis-associated inflammatory signature. Conversely, pharmacological or genetic targeting of Hdac7 and other class IIa HDACs attenuates LPS-inducible glycolysis and accompanying inflammatory responses in macrophages. We show that an Hdac7-Pkm2 complex acts as an immunometabolism signaling hub, whereby Pkm2 deacetylation at lysine 433 licenses its proinflammatory functions. Disrupting this complex suppresses inflammatory responses in vitro and in vivo. Class IIa HDACs are thus pivotal intermediates connecting TLR-inducible glycolysis to inflammation via Pkm2.Entities:
Keywords: glycolysis; histone deacetylases; immunometabolism; inflammation; lysine acetylation; macrophage; post-translational modification; pyruvate kinase; toll-like receptor
Mesh:
Substances:
Year: 2020 PMID: 32101747 DOI: 10.1016/j.celrep.2020.02.007
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423